# Prognostic Biomarkers in Patients With Urothelial Carcinoma

> **NCT04872036** · — · COMPLETED · sponsor: **Hellenic Cooperative Oncology Group** · enrollment: 66 (actual)

## Conditions studied

- Bladder Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04872036
- **Lead sponsor:** Hellenic Cooperative Oncology Group
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2000-05
- **Primary completion:** 2017-03
- **Final completion:** 2017-06
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2021-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04872036

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04872036, "Prognostic Biomarkers in Patients With Urothelial Carcinoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04872036. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*